Results 211 to 212 of about 29,801 (212)

ERBB2 status and benefit from adjuvant tamoxifen in ERα-positive postmenopausal breast carcinoma

Cancer Letters, 2001
We examined the relation between ERBB2 gene expression (as determined by a real-time quantitative RT-PCR assay) and the response to adjuvant tamoxifen therapy in a well-defined cohort of 125 ERalpha-positive postmenopausal patients with breast cancer. Although ERBB2 overexpression was associated with shorter relapse-free survival in univariate analysis
Bieche, I, Onody, P, Lerebours, F, Tozlu, S, Hacene, K, Andrieu, C, Vidaud, M, Tubiana-Hulin, M, Spyratos, F, Lidereau, R   +9 more
openaire   +2 more sources